Spinal Cord Stimulators Market. The global spinal cord stimulators market is on an accelerated growth path, projected to ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

Boston Scientific (NYSE:BSX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Wednesday. Several other research analysts also ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PFG Investments LLC boosted its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities ...

The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

I’m still a believer in the story at Boston Scientific, but the valuation situation remains challenging. I do think there’s a credible chance of BSX generating 10% long-term revenue growth and ...

The Farapulse (left) and Watchman FLX Pro (right) systems. [Images courtesy of Boston Scientific] Boston Scientific (NYSE: BSX) + CEO Mike Mahoney expects more growth for the company in 2025.